IOS PRESS IMAGE: THE MOST STRIKING FINDINGS WERE THE MONONUCLEAR ATTACK ON CEREBRAL AMYLOID ANGIOPATHY (HISTIOCYTIC VASCULITIS) WITH FIBRINOID NECROSIS (LEFT, AΒ IMMUNOHISTOCHEMISTRY [4G8]), AND FOCALLY PRONOUNCED AΒ PLAQUE PHAGOCYTOSIS (RIGHT, CD163 IMMUNOHISTOCHEMISTRY), THE COMBINATION OF WHICH DOES NOT OTHERWISE EXIST IN NATURE. CREDIT: JOURNAL OF ALZHEIMER’S DISEASE. Amsterdam, May 24, 2023 – In a noteworthy case...
Tag: <span>lecanemab</span>
Post
Is lecanemab the Alzheimer’s drug that will finally make a difference?
December 8, 2022 6:00 AM ET JON HAMILTON In a large study, experimental drug lecanemab was able to slow down Alzheimer’s, but not stop it. Some researchers think the drug will become the first to help many patients; others have questions. Cemile Bingol/Getty Images A drug that offers a small benefit to Alzheimer’s patients is...